BALDWIN BROTHERS LLC/MA – Regeneron Pharmaceuticals, Inc. Transaction History
BALDWIN BROTHERS LLC/MA portfolio value:
$244,000
portfolio value
BALDWIN BROTHERS LLC/MA quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -6.84% | -26 shares | 19K | $688.87 | 354 |
| Q2 2022 | share | Decrease | -59.87% | -567 shares | -436K | $591.13 | 380 |
| Q1 2022 | share | Decrease | -93.04% | -12.66K shares | -7.93M | $698.42 | 947 |
| Q4 2021 | share | Increase | +6.17% | 791 shares | 837K | $642.51 | 13.60K |
| Q3 2021 | share | Increase | +5.13% | 625 shares | 947K | $605.18 | 12.81K |
| Q2 2021 | share | Increase | +3.94% | 462 shares | 1.26M | $558.54 | 12.19K |
| Q1 2021 | share | Increase | +3.48% | 395 shares | 74K | $473.14 | 11.73K |
| Q4 2020 | share | Increase | +40.22% | 3.25K shares | 951K | $483.11 | 11.33K |
| Q3 2020 | share | Increase | +33.66% | 2.03K shares | 753K | $559.78 | 8.08K |
| Q2 2020 | share | Increase | +8.00% | 448 shares | 1.03M | $623.65 | 6.04K |
| Q1 2020 | share | Increase | 0.00% | 5.6K shares | 2.73M | $488.29 | 5.6K |